MONROVIA, Calif., Nov. 29 STAAR Surgical Company(Nasdaq: STAA), a leading developer, manufacturer and marketer of minimallyinvasive ophthalmic products, today announced that it will present at the BMOCapital Markets 2007 Focus on Healthcare Conference on Tuesday,December 4, 2007 at the Millennium Broadway Hotel in New York City. Barry G.Caldwell, STAAR Surgical's Chief Executive Officer, will discuss the Company'sbusiness strategy and historical financial performance at 2:00 p.m. EasternTime.
Attendance at the conference is by invitation only. A live audio webcastof STAAR's presentation may be accessed through the Company's website athttp://www.staar.com. An archived replay of the presentation will be availableafter the live presentation and can also be accessed at http://www.staar.com.
About STAAR Surgical
STAAR is a leader in the development, manufacture and marketing ofminimally invasive ophthalmic products employing proprietary technologies.STAAR's products are used by ophthalmic surgeons and include the VisianICL(TM), a tiny, flexible lens implanted to correct refractive errors, as wellas innovative products designed to improve patient outcomes for cataracts andglaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDAfor use in treating myopia, has received CE Marking and is sold in more than40 countries. More than 85,000 ICLs have been sold worldwide. More informationis available at http://www.staar.com.CONTACT: Investors EVC Group Douglas Sherk/ Donald Takaya, 415-896-6820 Media EVC Group Steve DiMattia, 646-201-5445
SOURCE STAAR Surgical